Cas:885271-33-0 ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate manufacturer & supplier

Chemical Name:ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate

CAS.NO:885271-33-0

Synonyms:ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate

Molecular Formula:C₁₀H₉N₃O₄

Molecular Weight:235.19600

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:89.42000

Exact Mass:235.05900

LogP:1.94240

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate Use and application,ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate technical grade,usp/ep/jp grade.

Related News: The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises. ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate manufacturer The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises. ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate vendor The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. ethyl 5-nitroimidazo[1,2-a]pyridine-3-carboxylate factory The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.